Serum miR-1290 as a marker of pancreatic cancer-response

Clinical Cancer Research

Volumn 19, Issue 18, 2013, Pages 5252-5253

  Li, Ang ^a   Yu, Jun ^a   Kim, Haeryoung ^a   Wolfgang, Christopher L ^a   Canto, Marcia Irene ^a,b   Hruban, Ralph H ^a,b   Goggins, Michael ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1290; MICRORNA 486 3P; UNCLASSIFIED DRUG;

BLOOD LEVEL; CANCER PROGNOSIS; ERYTHROCYTE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; LETTER; NONHUMAN; OBSTRUCTIVE JAUNDICE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HUMANS; MICRORNAS; PANCREATIC NEOPLASMS; TRANSCRIPTOME;

EID: 84884546643     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-1899     Document Type: Letter

References (1)

1. Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 2012;18:981-92.